AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 124 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,174,283 | +202.7% | 515,233 | +122.4% | 0.01% | +250.0% |
Q2 2023 | $718,298 | +92.3% | 231,709 | -13.8% | 0.00% | +100.0% |
Q1 2023 | $373,447 | +259238.2% | 268,667 | +270.2% | 0.00% | 0.0% |
Q4 2022 | $144 | -99.9% | 72,578 | +145.9% | 0.00% | 0.0% |
Q3 2021 | $158,000 | +4.6% | 29,517 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $151,000 | -90.8% | 29,517 | -87.9% | 0.00% | -85.7% |
Q1 2021 | $1,645,000 | +45.3% | 244,400 | -1.3% | 0.01% | +40.0% |
Q4 2020 | $1,132,000 | +1472.2% | 247,725 | +1231.9% | 0.01% | – |
Q3 2020 | $72,000 | -97.7% | 18,600 | -97.1% | 0.00% | -100.0% |
Q2 2020 | $3,072,000 | +1773.2% | 645,320 | +1794.4% | 0.02% | +1900.0% |
Q4 2019 | $164,000 | -83.1% | 34,064 | -89.8% | 0.00% | -85.7% |
Q3 2019 | $971,000 | – | 334,987 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |